Rabbit Recombinant Monoclonal PCYOX1 antibody. Suitable for WB and reacts with Human samples.
pH: 7.2 - 7.4
Preservative: 0.05% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine
ICC/IF | IP | Flow Cyt | WB | IHC-P | |
---|---|---|---|---|---|
Human | Not recommended | Not recommended | Not recommended | Tested | Not recommended |
Mouse | Not recommended | Not recommended | Not recommended | Predicted | Not recommended |
Rat | Not recommended | Not recommended | Not recommended | Predicted | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/10000 - 1/50000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Select an associated product type
Prenylcysteine oxidase that cleaves the thioether bond of prenyl-L-cysteines, such as farnesylcysteine and geranylgeranylcysteine (PubMed:10585463, PubMed:11078725, PubMed:12186880). Only active against free prenylcysteines and not prenylcysteine residues within prenylated proteins or peptides (By similarity). Involved in the final step in the degradation of prenylated proteins, by degrading prenylcysteines after the protein has been degraded (PubMed:10585463).
KIAA0908, PCL1, UNQ597/PRO1183, PCYOX1, Prenylcysteine oxidase 1, Prenylcysteine lyase
Rabbit Recombinant Monoclonal PCYOX1 antibody. Suitable for WB and reacts with Human samples.
pH: 7.2 - 7.4
Preservative: 0.05% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
PCYOX1 also known as prenylcysteine oxidase 1 functions as an oxidase enzyme that specifically processes prenylated proteins by cleaving the thioether bond of prenylcysteines. This protein has a molecular weight of approximately 64 kDa. Expression of PCYOX1 is noted across various tissue types with marked presence in liver and kidney. Its localization suggests a possible involvement in cellular metabolism associated with lipid-modified proteins.
The PCYOX1 protein enables degradation of prenylcysteine derivatives facilitating cellular processes related to lipid anchoring of signaling molecules. It is part of a larger complex responsible for prenylated protein turnover contributing to cellular regulation by modulating levels of signal transduction proteins anchored to membranes through prenylation.
PCYOX1 participates in the isoprenoid metabolic pathway and is intricately linked to the post-translational modification pathway. This positions it alongside other prenylation-dependent proteins such as farnesylated and geranylgeranylated proteins which rely on similar modifications to localize to their functional membrane-bound states.
Alterations in PCYOX1 activity have connections to conditions like cancer and cardiovascular diseases. Dysregulation affects protein prenylation levels impacting pathways tied to oncogenes and proteins like Ras which is often implicated in malignancies. Likewise abnormal lipid metabolism associated with PCYOX1 links to cholesterol-related cardiovascular diseases influenced by protein interactions within these pathways.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
All lanes: Western blot - Anti-PCYOX1 antibody [EPR5611] (ab124966) at 1/10000 dilution
Lane 1: SH-SY5Y cell lysates at 10 µg
Lane 2: HepG2 cell lysates at 10 µg
Lane 3: 293T cell lysates at 10 µg
Lane 4: HeLa cell lysates at 10 µg
All lanes: HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 57 kDa
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody.
Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Blocking and dilution buffer: 5% NFDM/TBST.
All lanes: Western blot - Anti-PCYOX1 antibody [EPR5611] (ab124966) at 1/10000 dilution
Lane 1: A431 (Human epidermoid carcinoma epithelial cell) cytoplasm lysate at 20 µg
Lane 2: A431 (Human epidermoid carcinoma epithelial cell) membrane lysate at 20 µg
Lane 3: A431 (Human epidermoid carcinoma epithelial cell) nuclear lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 57 kDa
Exposure time: 3s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com